Abstract
Purpose
To assess the obliteration rate, functional outcome, hemorrhagic complication, and mortality rates of exclusion treatment of low-grade brain arteriovenous malformations (BAVMs) (Spetzler and Martin grades (SMGs) 1 and 2), either ruptured or unruptured.
Methods
Electronic databases—Ovid MEDLINE and PubMed—were searched for studies in which there was evidence of exclusion treatment of low-grade BAVMs treated either by endovascular, surgical, radiosurgical, or multimodality treatment. The primary outcome of interest was angiographic obliteration post-treatment and at follow-up. The secondary outcomes of interest were functional outcome (mRS), mortality rate, and hemorrhagic complication. Descriptive statistics were used to calculate rates and means.
Results
Eleven studies involving 1809 patients with low-grade BAVMs were included. Among these, 1790 patients treated by either endovascular, surgical, radiosurgical, or multimodality treatment were included in this analysis. Seventy-two percent of BAVMs were Spetzler-Martin grade II. The overall (i.e., including all exclusion treatment modalities) complete obliteration rate ranged from 36.5 to 100%. The overall symptomatic hemorrhagic complication rate ranged from 0 to 7.3%; procedure-related mortality ranged from 0 to 4.7%.
Conclusion
Our systematic review of the literature reveals a high overall obliteration rate for low-grade BAVMs, either ruptured or unruptured, with low mortality rate and an acceptable post-treatment hemorrhagic complication rate. These results suggest that exclusion treatment of low-grade BAVMs may be safe and effective, regardless of the treatment modality chosen.
Similar content being viewed by others
Abbreviations
- BAVMs:
-
Brain arteriovenous malformations
- SMG:
-
Spetzler-Martin grade
- mRS:
-
Modified Rankin scale
- EVT:
-
Endovascular treatment
- SRS:
-
Stereotactic radiosurgery
References
Conger A, Kulwin C, Lawton MT, Cohen-Gadol AA (2015) Diagnosis and evaluation of intracranial arteriovenous malformations. Surg Neurol Int 6.https://doi.org/10.4103/2152-7806.156866
Nataraj A, Mohamed MB, Gholkar A et al (2014) Multimodality treatment of cerebral arteriovenous malformations. World Neurosurg 82:149–159. https://doi.org/10.1016/j.wneu.2013.02.064
Deruty R, Pelissou-Guyotat I, Morel C, et al (1998) Reflections on the management of cerebral arteriovenous malformations. Surg Neurol 50:245–255; discussion 255–256. https://doi.org/10.1016/s0090-3019(98)00082-2
Hillman J (2001) Population-based analysis of arteriovenous malformation treatment. J Neurosurg 95:633–637. https://doi.org/10.3171/jns.2001.95.4.0633
Brown RD, Wiebers DO, Forbes GS (1990) Unruptured intracranial aneurysms and arteriovenous malformations: frequency of intracranial hemorrhage and relationship of lesions. J Neurosurg 73:859–863. https://doi.org/10.3171/jns.1990.73.6.0859
Brown RD, Wiebers DO, Forbes G et al (1988) The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 68:352–357. https://doi.org/10.3171/jns.1988.68.3.0352
Hamilton MG, Spetzler RF (1994) The prospective application of a grading system for arteriovenous malformations. Neurosurgery 34:2–6 (discussion 6-7)
Heros RC, Korosue K, Diebold PM (1990) Surgical excision of cerebral arteriovenous malformations: late results. Neurosurgery 26:570–577; discussion 577–578. https://doi.org/10.1097/00006123-199004000-00003
Morgan MK, Johnston IH, Hallinan JM, Weber NC (1993) Complications of surgery for arteriovenous malformations of the brain. J Neurosurg 78:176–182. https://doi.org/10.3171/jns.1993.78.2.0176
Mohr JP, Parides MK, Stapf C et al (2014) Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet Lond Engl 383:614–621. https://doi.org/10.1016/S0140-6736(13)62302-8
Mohr JP, Overbey JR, von Kummer R et al (2017) Functional impairments for outcomes in a randomized trial of unruptured brain AVMs. Neurology 89:1499–1506. https://doi.org/10.1212/WNL.0000000000004532
Hamilton MGSR (1994) The prospective application of a grading system for arteriovenous malformations. Neurosurgery 34:2–7
Liberati A, Altman DG, Tetzlaff J, et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339.https://doi.org/10.1136/bmj.b2700
Burns PB, Rohrich RJ, Chung KC (2011) The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 128:305–310. https://doi.org/10.1097/PRS.0b013e318219c171
Institute of Medicine (US) Committee on Standards for Systematic Reviews of Comparative Effectiveness Research (2011) Finding what works in health care: standards for systematic reviews. National Academies Press (US), Washington (DC)
Hung AL, Yang W, Westbroek EM et al (2017) Differences in functional outcome across subtypes with Spetzler-Martin grade II arteriovenous malformations. Neurosurgery 81:441–449. https://doi.org/10.1093/neuros/nyw140
Baharvahdat H, Blanc R, Fahed R et al (2019) Endovascular treatment for low-grade (Spetzler-Martin I-II) brain arteriovenous malformations. AJNR Am J Neuroradiol 40:668–672. https://doi.org/10.3174/ajnr.A5988
Iosif C, de Lucena AF, Abreu-Mattos LG et al (2019) Curative endovascular treatment for low-grade Spetzler-Martin brain arteriovenous malformations: a single-center prospective study. J NeuroInterventional Surg 11:699–705. https://doi.org/10.1136/neurintsurg-2018-014390
Potts MB, Lau D, Abla AA et al (2015) Current surgical results with low-grade brain arteriovenous malformations. J Neurosurg 122:912–920. https://doi.org/10.3171/2014.12.JNS14938
Morgan MK, Rochford AM, Tsahtsarlis A et al (2004) Surgical risks associated with the management of grade I and II brain arteriovenous malformations. Neurosurgery 54:832–837; discussion 837–839. https://doi.org/10.1227/01.neu.0000114264.78966.be
Aboukaïs R, Quidet M, Baroncini M et al (2017) Grade 1 Spetzler and Martin cerebral ruptured arteriovenous malformations treated by microsurgery: Poor functional outcome is related to injury from haemorrhage. Neurochirurgie 63:69–73. https://doi.org/10.1016/j.neuchi.2016.10.010
Moon K, Levitt MR, Almefty RO et al (2015) Safety and efficacy of surgical resection of unruptured low-grade arteriovenous malformations from the modern decade. Neurosurgery 77:948–952; discussion 952–953. https://doi.org/10.1227/NEU.0000000000000968
Sisti MB, Kader A, Stein BM (1993) Microsurgery for 67 intracranial arteriovenous malformations less than 3 cm in diameter. J Neurosurg 79:653–660. https://doi.org/10.3171/jns.1993.79.5.0653
Kano H, Lunsford LD, Flickinger JC et al (2012) Stereotactic radiosurgery for arteriovenous malformations, part 1: management of Spetzler-Martin grade I and II arteriovenous malformations. J Neurosurg 116:11–20. https://doi.org/10.3171/2011.9.JNS101740
Ding D, Starke RM, Kano H et al (2017) Stereotactic radiosurgery for ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible Spetzler-Martin grade I and II arteriovenous malformations: a multicenter study. World Neurosurg 102:507–517. https://doi.org/10.1016/j.wneu.2017.03.061
Wang A, Mandigo GK, Feldstein NA et al (2020) Curative treatment for low-grade arteriovenous malformations. J Neurointerventional Surg 12:48–54. https://doi.org/10.1136/neurintsurg-2019-015115
Teo MK, Young AMH, St George EJ (2016) Comparative surgical outcome associated with the management of brain arteriovenous malformation in a regional neurosurgical centre. Br J Neurosurg 30:623–630. https://doi.org/10.1080/02688697.2016.1199776
van Beijnum J, van der Worp HB, Buis DR et al (2011) Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA 306:2011–2019. https://doi.org/10.1001/jama.2011.1632
Magro E, Gentric J-C, Batista AL et al (2018) The Treatment of Brain AVMs Study (TOBAS): an all-inclusive framework to integrate clinical care and research. J Neurosurg 128:1823–1829. https://doi.org/10.3171/2017.2.JNS162751
Stefani MA, Sgarabotto Ribeiro D, Mohr JP (2019) Grades of brain arteriovenous malformations and risk of hemorrhage and death. Ann Clin Transl Neurol 6:508–514. https://doi.org/10.1002/acn3.723
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Sourour reports a conflict of interest with Medtronic, Balt Extrusion, Microvention (consultant), and Stock/Stock Options: Medina. Prof. Clarençon reports a conflict of interest with Medtronic, Guerbet, Balt Extrusion (payment for readings), and Codman Neurovascular (core lab). The other authors report no conflicts of interest.
Ethical approval
For this type of study, formal consent is not required.
Informed consent
Not required.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Talaat, M., Premat, K., Lenck, S. et al. Exclusion treatment of ruptured and unruptured low-grade brain arteriovenous malformations: a systematic review. Neuroradiology 64, 5–14 (2022). https://doi.org/10.1007/s00234-021-02714-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-021-02714-x